Shudong Liu

772 total citations
21 papers, 522 citations indexed

About

Shudong Liu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Shudong Liu has authored 21 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Shudong Liu's work include Metabolism, Diabetes, and Cancer (4 papers), Mitochondrial Function and Pathology (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Shudong Liu is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Mitochondrial Function and Pathology (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Shudong Liu collaborates with scholars based in China and United States. Shudong Liu's co-authors include Qi Wang, Bai Zhang, Guizhen Tian, Ling Gao, Shizhan Ma, Chunxiao Yu, Fei Jing, Yejun Qin, Jiajun Zhao and Yajun Xi and has published in prestigious journals such as PLoS ONE, Frontiers in Pharmacology and BMC Plant Biology.

In The Last Decade

Shudong Liu

19 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shudong Liu China 10 273 130 101 98 98 21 522
Jinying Wei China 13 331 1.2× 92 0.7× 59 0.6× 76 0.8× 81 0.8× 22 647
Yaru Wu China 11 297 1.1× 147 1.1× 93 0.9× 98 1.0× 58 0.6× 22 654
Ruyuan Deng China 12 242 0.9× 63 0.5× 121 1.2× 61 0.6× 60 0.6× 18 461
Stefanie Bittner United States 9 280 1.0× 105 0.8× 65 0.6× 59 0.6× 101 1.0× 13 520
Simon M. Schultze Switzerland 5 380 1.4× 167 1.3× 66 0.7× 153 1.6× 94 1.0× 6 697
María Valero‐Muñoz Spain 16 247 0.9× 98 0.8× 36 0.4× 117 1.2× 116 1.2× 28 917
Yifen Wang China 15 281 1.0× 165 1.3× 56 0.6× 51 0.5× 73 0.7× 34 616
Ki-Up Lee South Korea 8 426 1.6× 138 1.1× 62 0.6× 112 1.1× 109 1.1× 9 792
Meiting Li China 15 423 1.5× 124 1.0× 89 0.9× 44 0.4× 39 0.4× 46 765
Meixiu Jiang China 16 257 0.9× 90 0.7× 89 0.9× 142 1.4× 28 0.3× 40 616

Countries citing papers authored by Shudong Liu

Since Specialization
Citations

This map shows the geographic impact of Shudong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shudong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shudong Liu more than expected).

Fields of papers citing papers by Shudong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shudong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shudong Liu. The network helps show where Shudong Liu may publish in the future.

Co-authorship network of co-authors of Shudong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shudong Liu. A scholar is included among the top collaborators of Shudong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shudong Liu. Shudong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ling, Xueping, B. Zhang, Haojie Ren, et al.. (2025). Preparation and epitope identification of a novel monoclonal antibody against 3A protein of Senecavirus A. Veterinary Microbiology. 303. 110442–110442. 3 indexed citations
2.
Yang, Ping, et al.. (2025). Severe tolvaptan-associated hyperglycemia: a case report. Journal of Medical Case Reports. 19(1). 314–314.
3.
Liu, Shudong, et al.. (2025). Busulfan damages spermatogenic function by inducing orchitis. PLoS ONE. 20(7). e0322721–e0322721.
4.
Yang, Xiaoxiao, et al.. (2025). Effect of liraglutide on the dysglycemia, inflammation, and gut microbiota in prediabetic KKay mice. Frontiers in Pharmacology. 16. 1714859–1714859. 1 indexed citations
5.
Zhao, Libo, et al.. (2024). Association between triglyceride and depression: A systematic review and meta-analysis. PLoS ONE. 19(10). e0311625–e0311625. 3 indexed citations
6.
Yang, Ping, et al.. (2024). Asprosin: its function as a novel endocrine factor in metabolic-related diseases. Journal of Endocrinological Investigation. 47(8). 1839–1850. 9 indexed citations
7.
Liu, Shudong, Fengxia Zhang, Xinhuan Su, et al.. (2023). The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP/PS1 mice. Journal of Translational Medicine. 21(1). 657–657. 7 indexed citations
8.
Xu, Xia, et al.. (2022). Effect of Selenium Treatment on Central Insulin Sensitivity: A Proteomic Analysis in β-Amyloid Precursor Protein/Presenilin-1 Transgenic Mice. Frontiers in Molecular Neuroscience. 15. 931788–931788. 7 indexed citations
9.
Liu, Shudong, et al.. (2021). Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK). Journal of Endocrinological Investigation. 44(8). 1753–1765. 12 indexed citations
10.
Xu, Lu, Juan Liao, Li Liu, et al.. (2021). The relation between aortic arch branching types and the location of large vessel occlusion in cardioembolic stroke. Journal of Clinical Neuroscience. 89. 171–176. 1 indexed citations
11.
Kong, Weilin, Junjie Yuan, Jiacheng Huang, et al.. (2021). Outcomes of Endovascular Therapy in Acute Basilar Artery Occlusion With Severe Symptoms. JAMA Network Open. 4(12). e2139550–e2139550. 24 indexed citations
12.
Li, Liyan, et al.. (2020). Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?. Therapeutic Advances in Endocrinology and Metabolism. 11. 2389878905–2389878905. 17 indexed citations
13.
Ma, Shizhan, et al.. (2019). <p>Therapeutic targets of hypercholesterolemia: HMGCR and LDLR</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1543–1553. 44 indexed citations
14.
Zhang, Chao, et al.. (2018). Long non-coding RNAs of switchgrass (Panicum virgatum L.) in multiple dehydration stresses. BMC Plant Biology. 18(1). 79–79. 32 indexed citations
15.
Zhang, Fengxia, Jianbo Chen, Ping Yang, et al.. (2018). SREBP-2, a new target of metformin?. Drug Design Development and Therapy. Volume 12. 4163–4170. 19 indexed citations
16.
Liu, Shudong, et al.. (2018). MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.. PubMed. 22(23). 8298–8305. 22 indexed citations
17.
Wang, Qi, et al.. (2018). AMPK-Mediated Regulation of Lipid Metabolism by Phosphorylation. Biological and Pharmaceutical Bulletin. 41(7). 985–993. 235 indexed citations
18.
Liu, Shudong, Fei Jing, Chunxiao Yu, et al.. (2015). AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver. PLoS ONE. 10(5). e0124951–e0124951. 62 indexed citations
19.
Xu, Kaijie, Yongfeng Wang, Wangqi Huang, et al.. (2015). Analysis of biochemical and physiological changes in wheat tissue culture using different germplasms and explant types. Acta Physiologiae Plantarum. 37(6). 10 indexed citations
20.
Xi, Yajun, Xuefeng Ma, Huan Zhong, et al.. (2010). Characterization of a male sterile mutant from progeny of a transgenic plant containing a leaf senescence-inhibition gene in wheat. Euphytica. 177(2). 241–251. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026